J
Jonas Busch
Researcher at Charité
Publications - 119
Citations - 2511
Jonas Busch is an academic researcher from Charité. The author has contributed to research in topics: Renal cell carcinoma & Prostate cancer. The author has an hindex of 23, co-authored 105 publications receiving 1836 citations. Previous affiliations of Jonas Busch include Humboldt University of Berlin.
Papers
More filters
Journal ArticleDOI
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer
Jörg Beyer,Peter Albers,Renske Altena,Jorge Aparicio,Carsten Bokemeyer,Jonas Busch,Richard Cathomas,Eva Cavallin-Ståhl,Noel W. Clarke,J. Claßen,Gabriella Cohn-Cedermark,Alv A. Dahl,Gedske Daugaard,U. De Giorgi,M. De Santis,M. de Wit,R. de Wit,Klaus-Peter Dieckmann,Martin Fenner,Karim Fizazi,Aude Flechon,Sophie D. Fosså,J. R. Germá Lluch,Jourik A. Gietema,Silke Gillessen,Aleksander Giwercman,J. T. Hartmann,Axel Heidenreich,Marcus Hentrich,Friedemann Honecker,Alan Horwich,Robert Huddart,S. Kliesch,Christian Kollmannsberger,Susanne Krege,M.P. Laguna,Leendert H. J. Looijenga,Anja Lorch,Jean-Pierre Lotz,Frank Mayer,Andrea Necchi,Nicola Nicolai,Janine Nuver,K. Oechsle,Jan Oldenburg,J. W. Oosterhuis,Thomas Powles,E. Rajpert-De Meyts,Oliver Rick,Giovanni Rosti,Roberto Salvioni,Mark Schrader,S. Schweyer,Felix Sedlmayer,Aslam Sohaib,Rainer Souchon,T. Tandstad,C. Winter,C. Wittekind +58 more
TL;DR: The main recommendations and controversies of this meeting are presented, with a particular focus on acute and late toxic effects as well as on survivorship issues.
Journal ArticleDOI
Diagnostic, prognostic and therapeutic implications of microRNAs in urologic tumors
TL;DR: The current knowledge of miRNA function in urologic tumors is illustrated and the attention of urologists is drawn to the future opportunities and challenges of this research field.
Journal ArticleDOI
Inhibiting WNT and NOTCH in renal cancer stem cells and the implications for human patients.
Annika Fendler,Daniel Bauer,Jonas Busch,Klaus Jung,Annika Wulf-Goldenberg,Séverine Kunz,Kun Song,Adam Myszczyszyn,Sefer Elezkurtaj,Bettina Erguen,Simone Jung,Wei Chen,Walter Birchmeier +12 more
TL;DR: It is shown that the proliferation of stem cells within organoids, PDX and spheres can be blocked by the concomitant inhibition of the NOTCH and WNT pathways.
Journal ArticleDOI
Reference genes for the relative quantification of microRNAs in renal cell carcinomas and their metastases
Zofia Wotschofsky,Helmuth-Alexander Meyer,Monika Jung,Annika Fendler,Annika Fendler,Ina Wagner,Carsten Stephan,Jonas Busch,Andreas Erbersdobler,Andreas Erbersdobler,Alexander C. Disch,Hans-Joachim Mollenkopf,Klaus Jung +12 more
TL;DR: The most stably expressed miRNAs were ascertained from microarray-based data of miRNA expression in nonmalignant and malignant samples from clear cell RCC and from corresponding distant RCC metastases using the geNorm and NormFinder algorithms.
Journal ArticleDOI
Piwi-interacting RNAs as novel prognostic markers in clear cell renal cell carcinomas
Jonas Busch,Bernhard Ralla,Monika Jung,Zofia Wotschofsky,Elena Trujillo-Arribas,Philipp Schwabe,Ergin Kilic,Annika Fendler,Klaus Jung +8 more
TL;DR: This study demonstrates that the expression levels of these piRNAs in primary non-metastatic and metastatic ccRCC tissue can serve as potential prognostic biomarkers in combination with clinicopathological factors.